This inventor holds 2 USPTO granted patents. Top assignees: Banner Life Sciences LLC, Banner Pharmacaps, Inc.. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Innovations by Zhi Liu: Advancements in Pharmaceutical Formulations
Introduction
Zhi Liu is an accomplished inventor based in Jamestown, NC (US), known for his significant contributions to pharmaceutical formulations. With a total of 2 patents, Liu has focused on enhancing the bioavailability of hydrophobic drugs, which is crucial for effective medication delivery.
Latest Patents
Liu's latest patents include innovative solutions for progesterone and orlistat. The first patent describes progesterone solutions that utilize fill materials for hydrophobic drugs, such as progesterone. This formulation contains the hydrophobic drug dissolved in one or more fatty acids, with concentrations ranging from about 7% to about 50% by weight. The inclusion of organic acids and pharmaceutically acceptable alcohols enhances the drug's bioavailability, leading to a higher dissolution rate compared to traditional methods. The second patent focuses on stable solutions of orlistat, which are designed for encapsulation in hard or soft capsules. This fill material allows for high loadings of orlistat and is stable at elevated temperatures, ensuring effective pharmaceutical dosage forms.
Career Highlights
Throughout his career, Zhi Liu has worked with notable companies such as Banner Life Sciences LLC and Banner Pharmacaps, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Liu has collaborated with professionals like Dana S Toops and Aqeel A Fatmi, further enhancing his work in the field of pharmaceutical formulations.
Conclusion
Zhi Liu's innovative patents and career achievements reflect his dedication to improving drug formulations and enhancing patient outcomes. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile